JP2005508892A - Ｇｃ−グロブリンの大規模生産のための精製方法、これにより得られる物質およびそれらの医薬用途 - Google Patents

Ｇｃ−グロブリンの大規模生産のための精製方法、これにより得られる物質およびそれらの医薬用途 Download PDF

Info

Publication number
JP2005508892A
JP2005508892A JP2003521270A JP2003521270A JP2005508892A JP 2005508892 A JP2005508892 A JP 2005508892A JP 2003521270 A JP2003521270 A JP 2003521270A JP 2003521270 A JP2003521270 A JP 2003521270A JP 2005508892 A JP2005508892 A JP 2005508892A
Authority
JP
Japan
Prior art keywords
globulin
exchange chromatography
ultrafiltration
anion exchange
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003521270A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005508892A5 (enExample
Inventor
ヨルゲンセン，シャーロッテ，スバーク
ラウーセン，インガ
ホウエン，ガンナー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Statens Serum Institut
Original Assignee
Statens Serum Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Serum Institut filed Critical Statens Serum Institut
Publication of JP2005508892A publication Critical patent/JP2005508892A/ja
Publication of JP2005508892A5 publication Critical patent/JP2005508892A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
JP2003521270A 2001-08-14 2002-08-12 Ｇｃ−グロブリンの大規模生産のための精製方法、これにより得られる物質およびそれらの医薬用途 Withdrawn JP2005508892A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101217 2001-08-14
PCT/DK2002/000531 WO2003016348A2 (en) 2001-08-14 2002-08-12 A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine

Publications (2)

Publication Number Publication Date
JP2005508892A true JP2005508892A (ja) 2005-04-07
JP2005508892A5 JP2005508892A5 (enExample) 2006-01-05

Family

ID=8160667

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003521270A Withdrawn JP2005508892A (ja) 2001-08-14 2002-08-12 Ｇｃ−グロブリンの大規模生産のための精製方法、これにより得られる物質およびそれらの医薬用途

Country Status (9)

Country Link
EP (1) EP1419177B1 (enExample)
JP (1) JP2005508892A (enExample)
AT (1) ATE393780T1 (enExample)
AU (1) AU2002321012B2 (enExample)
CA (1) CA2456843A1 (enExample)
DE (1) DE60226327T2 (enExample)
DK (1) DK1419177T3 (enExample)
ES (1) ES2305272T3 (enExample)
WO (1) WO2003016348A2 (enExample)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012029954A1 (ja) 2010-09-03 2012-03-08 国立大学法人徳島大学 新規Ｇｃグロブリンガラクトース脱糖体の製造方法
JP2012532932A (ja) * 2009-07-13 2012-12-20 アラーガン、インコーポレイテッド ボツリヌス神経毒素を得るためのプロセスおよびシステム
JP2013531623A (ja) * 2010-05-18 2013-08-08 アッヴィ・インコーポレイテッド タンパク質の精製装置および方法
WO2015087981A1 (ja) * 2013-12-13 2015-06-18 医療法人再生未来 ウシ初乳酵素処理物、その製造方法、組成物および飲食品
WO2016194914A1 (ja) * 2015-06-01 2016-12-08 再生ファーマ株式会社 乳酵素処理物、その製造方法、組成物および製品

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1778301A2 (en) * 2004-06-29 2007-05-02 Reliance Life Sciences Pvt., Ltd. Process for improvement of virus-safe biological fluids
CN100354301C (zh) * 2005-10-13 2007-12-12 南京工业大学 化学合成多肽的新型大规模分离制备技术
EP2682168A1 (en) 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
CN111632167B (zh) * 2014-04-15 2021-12-28 勃林格殷格翰国际公司 在制造生物制品期间连续灭活病毒的方法、装置和系统

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5177002A (en) * 1989-11-20 1993-01-05 Nobuto Yamamoto In vitro enzymatic conversion of glycosylated human vitamin D binding protein to a potent macrophage activating factor
ES2124702T3 (es) * 1990-04-11 1999-02-16 Brigham & Womens Hospital Usos terapeuticos de compuestos que se unen a actina.
US6268478B1 (en) * 1996-02-12 2001-07-31 Cedars-Sinai Medical Center Intracellular vitamin D binding protein

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020078306A (ja) * 2009-07-13 2020-05-28 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ ボツリヌス神経毒素を得るためのプロセスおよびシステム
JP2017070291A (ja) * 2009-07-13 2017-04-13 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ ボツリヌス神経毒素を得るためのプロセスおよびシステム
JP2021193103A (ja) * 2009-07-13 2021-12-23 アラーガン、インコーポレイテッドAllergan, Incorporated ボツリヌス神経毒素を得るためのプロセスおよびシステム
JP2012532932A (ja) * 2009-07-13 2012-12-20 アラーガン、インコーポレイテッド ボツリヌス神経毒素を得るためのプロセスおよびシステム
JP2016028601A (ja) * 2009-07-13 2016-03-03 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ ボツリヌス神経毒素を得るためのプロセスおよびシステム
JP2017002049A (ja) * 2010-05-18 2017-01-05 アッヴィ・インコーポレイテッド タンパク質の精製装置および方法
JP2013531623A (ja) * 2010-05-18 2013-08-08 アッヴィ・インコーポレイテッド タンパク質の精製装置および方法
WO2012029954A1 (ja) 2010-09-03 2012-03-08 国立大学法人徳島大学 新規Ｇｃグロブリンガラクトース脱糖体の製造方法
KR20160096089A (ko) * 2013-12-13 2016-08-12 사이세이 파마 씨오., 엘티디. 소 초유 효소 처리물, 그 제조방법, 조성물 및 식품
WO2015087981A1 (ja) * 2013-12-13 2015-06-18 医療法人再生未来 ウシ初乳酵素処理物、その製造方法、組成物および飲食品
JPWO2015087981A1 (ja) * 2013-12-13 2017-03-16 再生ファーマ株式会社 ウシ初乳酵素処理物、その製造方法、組成物および飲食品
US10322147B2 (en) 2013-12-13 2019-06-18 Saisei Pharma Co., Ltd. Enzyme-treated bovine colostrum, preparation method thereof, composition, and foods and beverages
KR102309707B1 (ko) * 2013-12-13 2021-10-06 사이세이 파마 씨오., 엘티디. 소 초유 효소 처리물, 그 제조방법, 조성물 및 식품
WO2016194914A1 (ja) * 2015-06-01 2016-12-08 再生ファーマ株式会社 乳酵素処理物、その製造方法、組成物および製品
JPWO2016194914A1 (ja) * 2015-06-01 2018-04-26 再生ファーマ株式会社 乳酵素処理物、その製造方法、組成物および製品
JP2022009514A (ja) * 2015-06-01 2022-01-14 再生ファーマ株式会社 乳酵素処理物、その製造方法、組成物および製品

Also Published As

Publication number Publication date
WO2003016348A3 (en) 2004-03-04
ES2305272T3 (es) 2008-11-01
DE60226327T2 (de) 2009-07-09
EP1419177B1 (en) 2008-04-30
EP1419177A2 (en) 2004-05-19
DE60226327D1 (de) 2008-06-12
DK1419177T3 (da) 2008-08-25
WO2003016348A2 (en) 2003-02-27
CA2456843A1 (en) 2003-02-27
ATE393780T1 (de) 2008-05-15
AU2002321012B2 (en) 2008-07-24

Similar Documents

Publication Publication Date Title
US6806355B2 (en) Purification process for large scale production of Gc-globulin, the Gc-globulin produced hereby, a use of Gc.globulin and a Gc-globulin medicinal product
US6281336B1 (en) Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
EP1084147B1 (en) Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
JP6876655B2 (ja) タンパク質の精製方法
HUE025853T2 (en) Antibody preparations
CN103153333B (zh) 补体因子h的纯化方法
PL165402B1 (pl) Sposób wydzielania oczyszczonego roztworu albuminy PL
EP1419177B1 (en) A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine
AU2002321012A1 (en) A purification process for large scale production of Gc-globulin, product obtained thereby and their use in medicine
Marmorstein et al. Epithelial permeability factor: a serum protein that condenses actin and opens tight junctions
US9145448B2 (en) Method for the isolation of haptoglobin
Lee Joergensen et al.
HK1151044B (en) Process for manufacturing immunoglobulins for intravenous administration and other immunoglobulin-like products
HK1151045B (en) Liquid immunoglobulin g (lgg) product
JPH02157298A (ja) 新規補体制御物質
JPH1036396A (ja) 高純度トランスサイレチン含有組成物の製造方法、高純度トランスサイレチン含有組成物および異型トランスサイレチン分泌抑制用組成物
MXPA00012230A (en) Process for producing immunoglobulins for intravenous administration and other immunoglobulin products

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050805

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050805

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20070718